0001179110-14-001911.txt : 20140204 0001179110-14-001911.hdr.sgml : 20140204 20140204191225 ACCESSION NUMBER: 0001179110-14-001911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140203 FILED AS OF DATE: 20140204 DATE AS OF CHANGE: 20140204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001436304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 BUSINESS PHONE: 818-587-4500 MAIL ADDRESS: STREET 1: 27200 WEST AGOURA ROAD STREET 2: SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Webster Jeffrey D CENTRAL INDEX KEY: 0001559582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35663 FILM NUMBER: 14574006 MAIL ADDRESS: STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC. STREET 2: 27200 WEST AGOURA ROAD, SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 4 1 edgar.xml FORM 4 - X0306 4 2014-02-03 0 0001436304 KYTHERA BIOPHARMACEUTICALS INC KYTH 0001559582 Webster Jeffrey D C/O KYTHERA BIOPHARMACEUTICALS, INC. 27200 WEST AGOURA ROAD, SUITE 200 CALABASAS CA 91301 0 1 0 0 Senior VP, Operations Common Stock 2014-02-03 4 M 0 4000 0.76 A 4000 D Common Stock 2014-02-03 4 S 0 2200 44.9993 D 1800 D Common Stock 2014-02-03 4 S 0 1800 45.8998 D 0 D Stock Option (right to buy) 0.76 2014-02-03 4 M 0 4000 0 D 2017-03-13 Common Stock 4000 50761 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2014. 100% of the shares subject to the option are fully vested and exercisable. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $44.57 to $45.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $45.515 to $46.33, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Keith Klein, as Attorney-in-Fact for Jeffrey D. Webster 2014-02-04